Tag: COVID-19

Merck requests FDA authorization for COVID-19 antiviral pill

By Joseph Choi

Read the full article from The Hill, here.

Merck has said that its pill, which targets the enzyme that allows the COVID-19 virus to make copies of itself, is likely effective against COVID-19 variants, including the highly infectious delta variant.

The U.S. government already has a supply agreement with Merck to acquire about 1.7 million courses of molnupiravir if it receives emergency use authorization from the FDA.

As Biden’s vaccinate-or-test mandate approaches, questions arise over enforcement

By Heidi Przybyla and Laura Strickler

Read the full article from NBC News, here.

President Joe Biden says his sweeping Covid-19 vaccination and testing mandate will boost the economy and save lives, but as businesses prepare for the new requirement, they’re wondering not only what will be in the regulation, but how it will be enforced.

The mandate, which will apply to organizations with at least 100 employees and cover an estimated 80 million workers, has already drawn threats of lawsuits from two dozen Republican attorneys general and prompted some people to vow to quit their jobs. But a greater challenge for the administration could lie within the agency tasked with ensuring compliance.

Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor

By Rebecca Robbins

Read the full article from The New York Times, here.

Moderna, whose coronavirus vaccine appears to be the world’s best defense against Covid-19, has been supplying its shots almost exclusively to wealthy nations, keeping poorer countries waiting and earning billions in profit.

After developing a breakthrough vaccine with the financial and scientific support of the U.S. government, Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, according to Airfinity, a data firm that tracks vaccine shipments.

What’s Delaying Vaccine Mandates?

By Andrew Ross Sorkin, Jason Karaian, Sarah Kessler, Stephen Gandel, Lauren Hirsch, Ephrat Livni and Anna Schaverien

Read the full article from The New York Times, here.

President Biden is headed to Chicago today, where he will make another push for companies to announce coronavirus vaccine mandates. He plans to meet with Scott Kirby of United Airlines and to visit a construction company considering a mandate, a White House official told DealBook. Throughout, the president will stress the message that vaccine mandates are crucial to the economic recovery. To bolster its case, the White House released a report this morning on the effects of corporate vaccine mandates to date.

Covid-19 prompts Erie County leaders to wonder: ‘When is it over?’

By Sandra Tan

Read the full article from Buffalo News, here.

In recent weeks, many overarching patterns remain unchanged. Overall cases are still rising, thanks to the Delta variant, but not as quickly as before. Hospitalizations and deaths remain elevated, after a steep August climb, but have leveled off and remain well below where we were in the winter and spring. Vaccination rates are rising at an unhurried pace.

A few Erie County legislators expressed a sense of longing that they believe is felt by many, including the vaccinated. People don’t want to be publicly shamed for wishing for fewer restrictions and a greater return to normalcy, they said, even as public health experts are urging people to remain patient.

‘We’re not out of danger’: A threat lingers even as new U.S. cases and deaths decline

By Adeel Hassan

Read the full article from The New York Times, here.

He worries about people dropping their use of masks and traveling more, as they have after earlier drops in new cases — actions that could help fuel a fresh surge in December and January.

The number of new daily cases in the United States has fallen 35 percent since Sept. 1, according to a New York Times database. The drop was especially stark in Southern states that had the highest infection rates during the Delta variant surge that started in June.

Florida, which averaged more than 20,000 new cases a day during much of August, is reporting fewer than 6,000 infections a day. Louisiana, which weeks ago was averaging more than 5,000 cases daily, has about 1,000 cases each day.